| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.25 | 0.05 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |